Kristalose
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
185 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Brain diseases | D001927 | HP_0001298 | G93.40 | 4 | 8 | 7 | 14 | 19 | 50 |
| Hepatic encephalopathy | D006501 | — | K72.91 | 4 | 8 | 7 | 14 | 19 | 50 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 1 | 7 | 6 | 6 | 15 | 30 |
| Fibrosis | D005355 | — | — | 1 | 6 | 6 | 5 | 13 | 26 |
| Constipation | D003248 | HP_0002019 | K59.0 | 1 | 3 | 7 | 6 | 5 | 21 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | 1 | — | 2 | 9 | 12 |
| End stage liver disease | D058625 | EFO_1001311 | K72.1 | 2 | 1 | 1 | 1 | 6 | 10 |
| Syndrome | D013577 | — | — | 1 | 1 | — | 3 | 4 | 9 |
| Liver failure | D017093 | HP_0001399 | K72.9 | 2 | — | — | 1 | 5 | 8 |
| Liver diseases | D008107 | HP_0002910 | K70-K77 | 1 | 3 | 2 | 2 | 1 | 7 |
Show 23 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colonoscopy | D003113 | — | — | — | 1 | 1 | — | 3 | 5 |
| Abdominal pain | D015746 | HP_0002027 | R10.9 | — | — | 1 | — | 3 | 4 |
| Critical illness | D016638 | — | — | — | — | 2 | — | 1 | 3 |
| Ascites | D001201 | HP_0001541 | R18 | — | — | 1 | — | 1 | 2 |
| Gastrointestinal diseases | D005767 | — | — | — | 1 | 1 | — | 1 | 2 |
| Digestive system diseases | D004066 | HP_0011024 | K92.9 | — | 1 | 1 | — | 1 | 2 |
| Delirium | D003693 | — | R41.0 | — | — | 1 | — | — | 1 |
| Systemic scleroderma | D012595 | EFO_0000717 | M34.0 | — | — | 1 | — | — | 1 |
| Lung diseases | D008171 | HP_0002088 | J98.4 | — | — | 1 | — | — | 1 |
| Interstitial lung diseases | D017563 | HP_0006530 | J84.89 | — | — | 1 | — | — | 1 |
Show 11 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | — | 1 | — | — | 2 | 3 |
| Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | 2 | 3 |
| Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | 1 | — | — | 1 | 2 |
| Premature birth | D047928 | EFO_0003917 | O60 | 1 | 1 | — | — | — | 2 |
| Covid-19 | D000086382 | — | — | — | 2 | — | — | — | 2 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | — | — | — | 1 |
| Multiple myeloma | D009101 | — | C90.0 | — | 1 | — | — | — | 1 |
| Plasma cell neoplasms | D054219 | — | — | — | 1 | — | — | — | 1 |
| Aids dementia complex | D015526 | EFO_0002608 | — | — | 1 | — | — | — | 1 |
| Rosacea | D012393 | — | L71 | — | 1 | — | — | — | 1 |
Show 5 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | 4 | 6 |
| Crohn disease | D003424 | EFO_0000384 | K50 | 1 | — | — | — | 1 | 2 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | 1 | — | — | — | — | 1 |
| Insulin resistance | D007333 | HP_0000855 | — | 1 | — | — | — | — | 1 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 1 | — | — | — | — | 1 |
| Gastric emptying | D005746 | — | — | 1 | — | — | — | — | 1 |
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | 1 | — | — | — | — | 1 |
| Tachycardia | D013610 | HP_0001649 | R00.0 | 1 | — | — | — | — | 1 |
| Orthostatic intolerance | D054971 | — | — | 1 | — | — | — | — | 1 |
| Burns | D002056 | — | T30.0 | 1 | — | — | — | — | 1 |
Show 5 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Communicable diseases | D003141 | — | — | — | — | — | — | 2 | 2 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | — | — | 2 | 2 |
| Alcoholic liver cirrhosis | D008104 | EFO_1000802 | K70.3 | — | — | — | — | 1 | 1 |
| Graft vs host disease | D006086 | — | D89.81 | — | — | — | — | 1 | 1 |
| Colonic diseases | D003108 | — | — | — | — | — | — | 1 | 1 |
| Anemia | D000740 | HP_0001903 | D64.9 | — | — | — | — | 1 | 1 |
| Iron-deficiency anemia | D018798 | HP_0001891 | D50 | — | — | — | — | 1 | 1 |
| Deficiency diseases | D003677 | EFO_1001067 | E63 | — | — | — | — | 1 | 1 |
| Iron deficiencies | D000090463 | — | — | — | — | — | — | 1 | 1 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 1 | 1 |
Show 32 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | — |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Kristalose – Cumberland Pharmaceuticals
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use